AlzeCure highlighted in a report on Parkinson’s and Alzheimer’s

A new report from Invest Stockholm conducts a review of knowledge about neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Both the region’s academic research and selected companies are presented here.

The report highlights one of Flemingsberg’s knowledge companies: AlzeCure. Here, the company’s CEO Martin Jönsson talks about the development of new treatments for Alzheimer’s disease.

It is estimated that the number of people with dementia will increase from 50 million today to 150 million in 2050. Alzheimer’s disease is the most common form of dementia and is a major cause of disability and dependency among old people worldwide. Parkinson’s disease is the second most common age-related neurodegenerative disorder and can also have a devastating impact on quality of life.

Universities and research institutes in the greater Stockholm region are carrying out vital research into these diseases, which will help to achieve early diagnosis and reduce the impact of neurodegenerative conditions on people’s lives.

Read the new report from Invest Stockholm: Improving Quality of Life for People with Neurodegenerative Diseases

Photo: Anna Hugosson,

Biosfär: “We want to democratise the care of the elderly”

Biosfär took home first prize in the Södertörn Social Cup ideas contest, which rewards social innovations. The idea behind Biosfär is to give people in homes for the elderly and in nursing homes the opportunity to experience joint activities in virtual reality.

Sparla helps you to sustainable personal finances

Sparla is the fintech – financial technology – app that will make your personal finances "financially fit". Recently, the service was awarded second prize in the Södertörn Social Cup. The service is now being developed to take the step from the student world to the general public.

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.


Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

Go to Top